[go: up one dir, main page]

SE9101863D0 - PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS - Google Patents

PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS

Info

Publication number
SE9101863D0
SE9101863D0 SE9101863A SE9101863A SE9101863D0 SE 9101863 D0 SE9101863 D0 SE 9101863D0 SE 9101863 A SE9101863 A SE 9101863A SE 9101863 A SE9101863 A SE 9101863A SE 9101863 D0 SE9101863 D0 SE 9101863D0
Authority
SE
Sweden
Prior art keywords
peptides
hiv
vaccine composition
starms
procedures
Prior art date
Application number
SE9101863A
Other languages
Swedish (sv)
Inventor
J Blomberg
Original Assignee
Replico Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical Ab filed Critical Replico Medical Ab
Priority to SE9101863A priority Critical patent/SE9101863D0/en
Publication of SE9101863D0 publication Critical patent/SE9101863D0/en
Priority to PCT/SE1992/000423 priority patent/WO1992022572A1/en
Priority to AU20230/92A priority patent/AU2023092A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Peptides, diagnostic antigens containing said peptides, a vaccine composition containing said peptides and an immunoassay method are described, said method permits discriminating between sera containing antibodies against different African HIV-1 strains and also African versus non-African HIV-1 strains, wherein at least one of said diagnostic antigen(s) is added to a positively diagnosed HIV-1 serum during the immunoassay and the discrimination is established based upon the selective reactions of said antigen(s) with the antibodies in the serum.
SE9101863A 1991-06-13 1991-06-13 PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS SE9101863D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9101863A SE9101863D0 (en) 1991-06-13 1991-06-13 PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS
PCT/SE1992/000423 WO1992022572A1 (en) 1991-06-13 1992-06-15 New hiv-1 gag and env peptides, diagnostic
AU20230/92A AU2023092A (en) 1991-06-13 1992-06-15 New hiv-1 gag and env peptides, diagnostic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101863A SE9101863D0 (en) 1991-06-13 1991-06-13 PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS

Publications (1)

Publication Number Publication Date
SE9101863D0 true SE9101863D0 (en) 1991-06-13

Family

ID=20383068

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9101863A SE9101863D0 (en) 1991-06-13 1991-06-13 PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS

Country Status (3)

Country Link
AU (1) AU2023092A (en)
SE (1) SE9101863D0 (en)
WO (1) WO1992022572A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290293A (en) * 1994-06-08 1995-12-20 Rupert Donald Holms Preparation which inhibits the autoimmune response in HIV, or SLE, patients
NO314588B1 (en) * 2000-09-04 2003-04-14 Bionor Immuno As HIV peptides, antigens, vaccine composition, immunoassay test kits and a method for detecting antibodies induced by HIV
ZA200407246B (en) * 2003-09-11 2005-06-29 Victor Anomah Ngu A vaccine
WO2007039458A2 (en) * 2005-09-21 2007-04-12 Cytos Biotechnology Ag Hiv peptide conjugates and uses thereof
EP1855112A1 (en) * 2006-05-10 2007-11-14 Inserm Method for the in vitro screening of compounds inhibiting production of infectious HIV-1 virions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
CA1339363C (en) * 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
ZA903492B (en) * 1989-05-15 1991-02-27 Akzo Nv T-lymphotropic retrovirus monoclonal antibodies
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS

Also Published As

Publication number Publication date
AU2023092A (en) 1993-01-12
WO1992022572A1 (en) 1992-12-23

Similar Documents

Publication Publication Date Title
AU600466B2 (en) Htlv-iii envelope peptides
RU94046284A (en) Method for detecting antibodies, method for performing c-cracking of blood components and set for detecting hcv-antibodies
AU6727798A (en) Method for simultaneous detection of hiv antigens and hiv antibodies
DE69133599D1 (en) ENTERICALLY TRANSMITTING NON-A / NON-B HEPATITIS VIRUS AGENS AND CHARACTERISTIC EPITOPES OF SELF
Muratori et al. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques
EP0248534A3 (en) Method of detecting aids virus infection
SE9000595D0 (en) NEW PEPTIDES, DIAGNOSTIC ANTIGENS AND AN IMMUNOASSAY METHOD
GR3005971T3 (en)
SE9101863D0 (en) PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS
NO175153C (en) polypeptides
Bürki et al. Equine lentivirus, comparative studies on four serological tests for the diagnosis of equine infectious anaemia
KR880014376A (en) Monoclonal Antibodies of the HIV Specific Antigen Region and Their Uses
Issel et al. Evolution of equine infectious anemia diagnostic tests: recognition of a need for detection of anti-EIAV glycoprotein antibodies
McArthur et al. A rapid micro-method for screening eel sera for antibodies against the digenean Telogaster opisthorchis Macfarlane, 1945.
KR930701975A (en) How to determine the sensitivity and / or specificity of a test system for antibody detection
ES2094124T3 (en) IMMUNOLOGICAL TEST OF ANTIBODIES AGAINST HIV.
EP0267622A3 (en) Method for detecting anti-adult t cell leukemia virus antibody
SE9002671D0 (en) NEW PEPTIDES, DIAGNOSTIC ANTIGENES, USE OF THEM AND VACCINES
Fuentes et al. Follow-up of HIV-infected individuals by semiquantitative detection of antibodies to p24 in ELISA
Erdei et al. Use of the ELISA-test for the serological screening for Aujeszky's virus infection in large-scale swine stocks.
KR890003946A (en) Method for preparing antigen of human immunodeficiency virus type 1 and use thereof as a diagnostic and therapeutic agent
Goto et al. Reply to van't Veer et al
Portetelle et al. Competition enzyme-linked immunosorbent assay(ELISA) for the diagnosis of bovine leukemia virus infection.
HK1000788A (en) Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof